BERGEM·HEALTH
Home Doctors Assoc. Prof. Dr. Rumeysa Atabey, MD
MEDICAL ONCOLOGY · MEMORIAL BAHÇELIEVLER

Assoc. Prof. Dr. Rumeysa Atabey, MD

Associate Professor of Medical Oncology · Memorial Bahçelievler Hospital
Assoc. Prof. Dr. Rumeysa Atabey is a medical oncologist at Memorial Bahçelievler Hospital. She trained at Istanbul University Faculty of Medicine, completing her internal medicine specialization in 2011 and her medical oncology sub-specialty in 2014. She has worked as a medical oncologist at Bakırköy Dr. Sadi Konuk Training and Research Hospital, Neolife Oncology Center, and Acıbadem Healthcare Group, with a clinical and research interest spanning colorectal, gastric and breast cancers.
Specialties: Oncology
15+
years in medicine
10+
years in medical oncology
Medical OncologyColorectal CancerGastric CancerBreast CancerInternal Medicine
A BergemHealth coordinator arranges contact with the professor within 24–48 hours on business days.
Direct contract with BergemHealth
CONSULTATION LANGUAGES
TR Turkish · native
EN English · professional
RU Russian · via BergemHealth coordinator
UK Ukrainian · via BergemHealth coordinator
ISTANBUL · 06/2026
EDUCATION & CAREER

Timeline

Career milestones.

2011
Internal Medicine Specialist
Istanbul Kanuni Sultan Süleyman Training and Research Hospital
2015-2016
Medical Oncology Specialist
Bakırköy Dr. Sadi Konuk Training and Research Hospital
2016-2021
Oncologist
Neolife Oncology Center, Istanbul
2021-recent
Associate Professor of Medical Oncology
Acıbadem Mehmet Ali Aydınlar University / Acıbadem Healthcare Group
recent-present
Medical Oncologist
Memorial Bahçelievler Hospital
PUBLICATIONS

Scientific work

Selected peer-reviewed publications.

  • 2013
    Oncol Lett
    «Age is a prognostic factor affecting survival in lung cancer patients»
    · co-author · 229 citations
  • 2015
    Medicine (Baltimore)
    «Renin-Angiotensin System Blockers May Prolong Survival of Metastatic Non-Small Cell Lung Cancer Patients Receiving Erlotinib»
    · co-author
  • 2016
    Medicine (Baltimore)
    «Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy»
    · co-author
  • 2013
    Asian Pac J Cancer Prev
    «Does Beta-blocker Therapy Improve the Survival of Patients with Metastatic Non-small Cell Lung Cancer?»
    · co-author · 61 citations
  • 2019
    Mol Biol Rep
    «The expression level of fibulin-2 in the circulating RNA (ctRNA) of epithelial tumor cells of peripheral blood and tumor tissue of patients with metastatic lung cancer»
    · co-author
  • 2014
    Tumor Biol
    «Coagulation tests show significant differences in patients with breast cancer»
    · co-author · 44 citations
REQUEST

Tell me about your case — I’ll read it personally.

Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.

Open the consultation form
  • Reply within 4 hours during business hours
  • Confidentiality guaranteed
  • Coordinator-translator inside the doctor’s office
  • Tumour board of 2–3 professors within 72 hours